Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2006-01-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes
NCT00529048
The Incretin Effect in Patients With Chronic Pancreatitis
NCT00638573
The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans
NCT01953393
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese patients with type 2 diabetes
Patients with type 2 diabetes and BMI\>33
Oral glucose tolerance test (OGTT)
Isoglycemic intravenous glucose infusion
Obese subjects with normal glucose tolerance
Subjects with normal glucose tolerance and BMI\>33
Oral glucose tolerance test (OGTT)
Isoglycemic intravenous glucose infusion
Lean subjects with type 2 diabetes
Patients with type 2 diabetes and BM\<25
Oral glucose tolerance test (OGTT)
Isoglycemic intravenous glucose infusion
Lean subjects with normal glucose tolerance
Subjects with normal glucose tolerance and BM\<25
Oral glucose tolerance test (OGTT)
Isoglycemic intravenous glucose infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral glucose tolerance test (OGTT)
Isoglycemic intravenous glucose infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal blood hemoglobin
* Informed consent
Exclusion Criteria
* Diabetic nephropathy
* Treatment with medication that can not be stopped for 12 hours
18 Years
70 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Gentofte, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital, Gentofte, Copenhagen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tina Vilsbøll, MD DMSc
Role: STUDY_CHAIR
Department of Internal Medicine F, Gentofte Hospital, University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gentofte Hospital, University of Copenhagen
Hellerup, Copenhagen, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMI-INK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.